Malignancy of brain tumors evaluated by proton magnetic resonance spectroscopy (1H-MRS) in vitro

Acta Neurochirurgica, Supplement

Volumn 76, Issue , 1999, Pages 17-20

  Czcrnicki, Z ^a  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

Glioma; Magnetic resonance spectroscopy; Meningioma; Metabolite ratios

Indexed keywords

CREATINE; CREATINE PHOSPHATE;

ARTICLE; BIOPSY; BRAIN; BRAIN TUMOR; DIFFERENTIAL DIAGNOSIS; ENERGY METABOLISM; GLIOMA; HUMAN; MENINGIOMA; MENINX; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDICTION AND FORECASTING; PROGNOSIS; REFERENCE VALUE;

BIOPSY; BRAIN; BRAIN NEOPLASMS; CREATINE; DIAGNOSIS, DIFFERENTIAL; ENERGY METABOLISM; GLIOMA; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MENINGEAL NEOPLASMS; MENINGES; MENINGIOMA; PHOSPHOCREATINE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REFERENCE VALUES;

EID: 0034575372     PISSN: 00651419     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6346-7_4     Document Type: Article

References (1)

1. Bottomley PA, Weiss RG (1999) Non-invasive magneticresonance detection of creatine depletion in non-viable infarcted myocardium. Lancet 351: 714-718